Amylyx Pharmaceuticals, Inc.盘中异动股价大跌5.05%报4.89美元

市场透视2025-06-03

北京时间2025年06月03日01时48分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价快速跳水5.05%。截至发稿，该股报4.89美元/股，成交量29.4653万股，换手率0.33%，振幅5.92%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-35.91百万美元，每股收益-0.42美元，毛利-156000.00美元，市盈率-1.58倍...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2540977427?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-03 01:48","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2540977427","market":"us","top_or_hot":-1,"title":"Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.05%报4.89美元","media":"市场透视","content":"<div>\n<p>北京时间2025年06月03日01时48分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价快速跳水5.05%。截至发稿，该股报4.89美元/股，成交量29.4653万股，换手率0.33%，振幅5.92%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-35.91百万美元，每股收益-0.42美元，毛利-156000.00美元，市盈率-1.58倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603014858950bc225&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.05%报4.89美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.05%报4.89美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-03 01:48 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603014858950bc225&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年06月03日01时48分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价快速跳水5.05%。截至发稿，该股报4.89美元/股，成交量29.4653万股，换手率0.33%，振幅5.92%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-35.91百万美元，每股收益-0.42美元，毛利-156000.00美元，市盈率-1.58倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603014858950bc225&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AMLX","symbol_name":"Amylyx Pharmaceuticals","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603014858950bc225&s=b","article_id":"2540977427","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603014858950bc225&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2540977427","pubTimestamp":1748886538,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年06月03日01时48分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.05%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.77%。其相关个股中，Lyra Therapeutics, Inc.、Plus Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大，Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1809.17%、1226.08%、709.70%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.，振幅分别为314.40%、130.92%、122.34%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AMLX":"Amylyx Pharmaceuticals","BK4007":"制药"},"translate_title":"Amylyx Pharmaceuticals, Inc. shares fell 5.05% to $4.89 during intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMLX":1},"content_text":"北京时间2025年06月03日01时48分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价快速跳水5.05%。截至发稿，该股报4.89美元/股，成交量29.4653万股，换手率0.33%，振幅5.92%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-35.91百万美元，每股收益-0.42美元，毛利-156000.00美元，市盈率-1.58倍。机构评级方面，在所有7家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.77%。其相关个股中，Lyra Therapeutics, Inc.、Plus Therapeutics, Inc.、Nutriband Inc C/Wts (To Pur Com)涨幅较大，Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1809.17%、1226.08%、709.70%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.，振幅分别为314.40%、130.92%、122.34%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc 是一家处于临床阶段的制药公司，致力于开发治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新型疗法。公司有一个运营分部，即研究和开发针对神经退行性疾病和内分泌疾病的疗法业务。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2540977427","isCrawlerRequest":true}

Amylyx Pharmaceuticals, Inc.盘中异动 股价大跌5.05%报4.89美元

精彩评论

Amylyx Pharmaceuticals, Inc.盘中异动股价大跌5.05%报4.89美元